We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXIA7:BMFBOVESPAAXIA Energia SA Non-Cum Perp Pfd Registered Shs C Analysis

Data as of 2026-06-17 - not real-time

R$51.68

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

AXIA Energia SA shows strong top‑line momentum with a 22% YoY revenue growth and robust operating margins (43.5% operating, 21.9% profit), yet the balance sheet is strained – a debt‑to‑equity ratio of 64.7 and negative free cash flow raise concerns. The stock trades at BRL 51.68, sitting just above its 20‑day SMA (50.78) but below the 50‑day (55.59) and 200‑day (54.85) averages, indicating a short‑term pull‑back within a neutral‑to‑bearish medium‑term context. Technicals are mixed: MACD shows a bullish signal with a modest positive histogram, while RSI is near 48 and price hovers between a support of 48.01 and resistance of 53.36. Market sentiment is extremely bullish (Fear‑Greed Index 92.75), but volatility is high at 32% and beta exceeds 1, suggesting the stock could swing sharply on new information such as the recent share offering tied to the Jirau stake acquisition.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 50‑day and 200‑day SMAs indicating limited upside
  • High volatility (32%) and beta (>1) increase short‑term price swings
  • Support level at 48.01 provides a floor but upside to 53.36 is constrained

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and margins support earnings potential
  • Elevated debt‑to‑equity (64.7) and negative free cash flow pose balance‑sheet risk
  • MACD bullish crossover suggests possible recovery if leverage is managed

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Renewable‑energy focus aligns with Brazil’s long‑term energy transition
  • Operating efficiency (high margins) can improve cash generation as projects mature
  • Current price near book value (P/B 1.21) offers a reasonable entry despite debt concerns

Key Metrics & Analysis

Financial Health

Revenue Growth22.10%
Profit Margin21.89%
ROE7.86%
ROA1.97%
Debt/Equity64.67
P/B Ratio1.2
Op. Cash FlowR$14.1B
Free Cash FlowR$-425324864
Industry P/E20.7

Technical Analysis

TrendNeutral
RSI48.3
SupportR$48.01
ResistanceR$53.36
MA 20R$50.78
MA 50R$55.59
MA 200R$54.85
MACDBullish
VolumeStable
Fear & Greed Index92.75

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta1.14
Volatility32.13%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.